Skip to main content

3 Result(s)

within Kelda M. Gardner Remove this filter Intensive / Critical Care Medicine Remove this filter

and

  1. No Access

    Article

    Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies

    Noam E. Kopmar, Megan Othus, Kelda M. Gardner, Carole Shaw, Anna B. Halpern… in Leukemia (2022)

  2. No Access

    Article

    Need for routine examination of left ventricular ejection fraction in patients with AML

    Hiba M. Khan, Kelda M. Gardner, Carole Shaw, Anna B. Halpern, Emily M. Huebner… in Leukemia (2020)

  3. No Access

    Article

    Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms

    Outcomes with “7 + 3” are often unsatisfactory in acute myeloid leukemia (AML). Trials demonstrating improved outcomes with high-dose cytarabine, addition of cladribine, or escalated anthracycline doses prompt...

    Anna B. Halpern, Megan Othus, Emily M. Huebner, Bart L. Scott, Pamela S. Becker… in Leukemia (2018)